CHPT vs EDIT · rev $417.1M vs rev $32.3M
ChargePoint Holdings Inc (CHPT) versus Editas Medicine Inc (EDIT) — a side-by-side from cached financials, not a winner call.
ChargePoint Holdings Inc (CHPT) is a specialty retail company listed on NYSE.
Editas Medicine Inc (EDIT) is a biotechnology company listed on NASDAQ.
Latest reported CHPT revenue for 2025-01-31 was $417.1M. Net income was -$277.1M. Revenue was down 17.7% from 2024-01-31 to 2025-01-31. CHPT currently screens at market cap $199.2M.
Latest reported EDIT revenue for 2024-12-31 was $32.3M. Net income was -$237.1M. Revenue was down 58.6% from 2023-12-31 to 2024-12-31. EDIT currently screens at market cap $375.2M.
CHPT currently screens at market cap $199.2M. EDIT currently screens at market cap $375.2M.
Not investment advice. Open the CHPT and EDIT stock pages for the full models.
Not investment advice.